This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home   Membership   Events   Resources   Accreditation May 26, 2010
People with AIDS more likely to develop cancers, research says
The Washington Post    Share   Share on FacebookTwitterShare on LinkedinE-mail article
When science turned AIDS several years ago from a fatal disease to a chronic illness that often can be managed with drugs, patients and doctors breathed a sigh of relief. Now they have a new worry. As people live longer with the virus, they are becoming far more likely than the rest of the population to develop cancers that were not previously associated with AIDS, research has found. "We're seeing high rates of head and neck cancer, lung cancer, kidney cancer, liver cancer and anal cancer," said John F. Deeken, director of head and neck oncology at Georgetown University Medical Center. More

Skin cancers rising at an alarming rate
McClatchy Newspapers via Dallas Morning News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
With sandy blond hair and light skin, Julie Moppin always freckled or burned in sunlight. But she still tried to tan. Now, decades later, her sunspots are attacking her. In five years, dermatologists have cut 40 current or potential cancers from her flesh, including two melanomas. Every three months, she returns half expecting more surgery. "It gets real old," she said. But she knows the alternative is worse. "My dad passed away last year from melanoma." More

Study shows new approach may have potential to screen for early-stage ovarian cancer
WebMD    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new screening approach shows promise for the detection of ovarian cancer in postmenopausal women at average risk of the disease, early testing suggests. The strategy uses a mathematical model that combines a patient's age and changes in blood levels of a protein called CA-125 over time to estimate risk of ovarian cancer. More

Platinum Medical Imaging: Excellence in Systems, Service, Parts, and Support

Platinum Medical Imaging specializes in working with Cancer Centers to provide factory certified, fully refurbished CT Scanners dedicated for Oncology. Visit us at

Scientists spot real 'smoking gun' in prostate cancer
HealthDay News via U.S. News & World Report    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The primary cause of prostate cancer could be the fusion of two genes and the subsequent abnormal prostate cell growth that results when receptors for the hormone androgen get blocked, a new study reveals. The implication is that standard efforts to treat the disease by targeting the androgen receptors might be missing the real "smoking gun," a University of Michigan Comprehensive Cancer Center team suggests. More

Why doesn't America want to cure cancer?
The Huffington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
My friend Dr. Toby Jenkins, a brilliant and highly energetic professor at George Mason University in Virginia, has breast cancer. I had not spoken to her in a while, and only learned of her health challenge when she posted it on Facebook. I immediately e-mailed Toby, asking if there was anything I could do. While awaiting her reply, I thought long and hard about the people I know who've died of cancer, who are cancer survivors, who are young like Toby (she is only 34) and battling this life-threatening disease. More

Study finds certain drugs can keep some forms of cancer in remission longer
The New York Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Using certain anti-cancer drugs for years at a time can help keep some types of cancer in remission longer, doctors reported May 20. In another finding, researchers said they had made progress on a long-sought goal: developing a way to screen healthy women for ovarian cancer, potentially catching tumors before they become virtually incurable. More

Yoga may help cancer patients after treatment
ABC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In the chemotherapy infusion room at the Staten Island University Hospital sit several cancer patients hooked up to IVs. But they aren't leafing through magazines or staring at a talk show and worrying about their health. Instead, their right legs are lifted up in the air, and they're circling their ankles clockwise while breathing deeply under the instruction of their yoga teacher. More

Go Beyond Billing

RadMax Radiation Oncology Billing Service combines advanced technology, total value, and dedicated customer service to meet all your AR management needs.

Study: No radiation after surgery OK for certain breast cancer patients
CNN    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Older breast cancer patients who have their small tumors surgically removed get little benefit from radiation treatment, according to a study released May 20 by the American Society of Clinical Oncologists. Researchers followed 636 women with early-stage, estrogen-receptor positive breast cancer. The standard therapy for this type of cancer is to surgically remove the tumor and then give the women a drug called tamoxifen. The tamoxifen is followed by intense radiation therapy to kill any remaining cancer cells. More

Pharmacyclics says lymphoma drug elicits responses
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Interim results from a small, early-stage trial of Pharmacyclics Inc's experimental drug for non-Hodgkin's lymphoma show that about 42 percent of patients responded to it, the company said May 20. The results from 19 patients were released by the American Society of Clinical Oncology, which will hold its annual meeting in early June. The company will have results from another 20 patients at the meeting, said Ramses Erdtmann, the company's vice president of finance. More

Radiation Oncology Consulting

Churchill Consulting, Inc., providing expert products and services since 1992. Premier product is DIRECTREES® (coding help application). Services include comprehensive chart audits, coding seminars, compliance programs, and QA Programs

2 early-stage Glaxo drugs show melanoma promise
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Two early-stage drugs from GlaxoSmithKline Plc have shown promise in tests against melanoma, the most deadly type of skin cancer, studies showed May 20. The company's head of oncology said researchers planned more tests of the so-called MEK and BRAF inhibitors on their own and in combination with each other. The MEK drug also will be tested alongside two other medicines from Novartis AG against various cancers. More

Roche's head of pharmaceuticals: Maintenance treatment in cancer will change pricing model
FirstWord    Share    Share on FacebookTwitterShare on LinkedinE-mail
According to the head of Roche's pharmaceutical division Pascal Soriot, the expected "paradigm shift" toward the long-term use of drugs for the treatment of cancer "will also change the pricing model" for such products. "Often, cancer drugs are administered for about six months together with chemotherapy and are then stopped," he said, adding that new data "have shown drugs can be used over a longer period of time and turn cancer into a chronic disease." More

Say "goodbye" to good enough.

Discover 10 ways TomoTherapy technology is being used to advance cancer care around the world.

RadOnc Weekly
James DeBois, Director of Advertising Sales, 469.420.2618   Download media kit
Patrick McCoy, Content Editor, 469.420.2603   Contribute news
This edition of RadOnc Weekly was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
May 19, 2010
May 12, 2010
May 5, 2010
April 28, 2010

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063